In the shifting landscape of product development, the pharma and biotech arenas increasingly emphasize the need to use less internal R&D resources, increase efficiency, and reduce costs. One product development strategy is the utilization of lean outsourcing models for clinical studies.
With global regulatory changes happening quickly and often, there is concern that sponsors need more robust systems to keep pace and have a global disclosure strategy in place.
Bioclinica has signed an agreement to be acquired by international private equity firm Cinven.
CROs H2O Clinical and Pharma Start have announced a merger to continue providing biostatistics, data management, clinical operations and medical writing to the pharmaceutical, medical device and biotechnology industries.
PPD announces the acquisition of Evidera, an evidence-based solutions provider.
OmniComm Systems announces the selection of its Trial One platform by a pharmaceutical company to automate its Phase I and BA/BE clinic.
Medidata announced that its cloud technology platform has been adopted by Israeli biotech, Pluristem Therapeutics.